BridgeBio Pharma, Inc. - Common Stock (BBIO)

CUSIP: 10806X102

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Equity / Common Stock
Shares outstanding
193,809,015
Total 13F shares
121,079,579
Share change
+2,410,737
Total reported value
$8,609,553,572
Put/Call ratio
35%
Price per share
$71.11
Number of holders
160
Value change
+$172,667,185
Number of buys
98
Number of sells
47

Security key

10806X102

Report period

Q4 2020

Institutions

160

Top holders

10

Top shareholders of BBIO - BridgeBio Pharma, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Kohlberg Kravis Roberts & Co. L.P.
13F
Company
18%
34,510,971
$1,294,852,000 30 Sep 2020
13F
VIKING GLOBAL INVESTORS LP
13F
Company
14%
26,620,991
$998,820,000 30 Sep 2020
13F
PERCEPTIVE ADVISORS LLC
13F
Company
3.5%
6,706,268
$251,619,000 30 Sep 2020
13F
VANGUARD GROUP INC
13F
Company
3.2%
6,295,118
$236,193,000 30 Sep 2020
13F
BlackRock Finance, Inc.
13F
Company
3.2%
6,120,137
$229,627,000 30 Sep 2020
13F
AMERICAN INTERNATIONAL GROUP, INC.
13F
Company
2.9%
5,619,928
$183,480,000 30 Sep 2020
13F
HHLR ADVISORS, LTD.
13F
Company
2.4%
4,711,604
$176,779,000 30 Sep 2020
13F
Aisling Capital Management LP
13F
Company
2.1%
3,989,412
$149,683,000 30 Sep 2020
13F
SC US (TTGP), LTD.
13F
Company
1.3%
2,544,738
$95,479,000 30 Sep 2020
13F
STATE STREET CORP
13F
Company
1.2%
2,354,508
$88,341,000 30 Sep 2020
13F
Cormorant Asset Management, LP
13F
Company
1.2%
2,265,762
$85,011,000 30 Sep 2020
13F
JANUS HENDERSON GROUP PLC
13F
Company
0.87%
1,691,461
$63,464,000 30 Sep 2020
13F
JPMORGAN CHASE & CO
13F
Company
0.67%
1,303,308
$48,353,000 30 Sep 2020
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.6%
1,158,655
$43,472,000 30 Sep 2020
13F
FMR LLC
13F
Company
0.53%
1,024,953
$38,455,000 30 Sep 2020
13F
NORTHERN TRUST CORP
13F
Company
0.44%
852,540
$31,988,000 30 Sep 2020
13F
CITIGROUP INC
13F
Company
0.37%
726,408
$27,255,000 30 Sep 2020
13F
TimesSquare Capital Management, LLC
13F
Company
0.33%
646,430
$24,254,000 30 Sep 2020
13F
LORD, ABBETT & CO. LLC
13F
Company
0.32%
614,724
$23,064,000 30 Sep 2020
13F
NORGES BANK
13F
Company
0.3%
573,063
$21,501,000 30 Sep 2020
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.29%
569,327
$21,361,000 30 Sep 2020
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.27%
522,543
$19,606,000 30 Sep 2020
13F
CREDIT SUISSE AG/
13F
Company
0.24%
462,087
$17,338,000 30 Sep 2020
13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/
13F
Company
0.21%
415,125
$15,575,000 30 Sep 2020
13F
Artal Group S.A.
13F
Company
0.21%
400,000
$15,008,000 30 Sep 2020
13F
Nuveen Asset Management, LLC
13F
Company
0.17%
322,641
$12,105,000 30 Sep 2020
13F
Nicholas Investment Partners, LP
13F
Company
0.15%
292,982
$10,993,000 30 Sep 2020
13F
FRANKLIN RESOURCES INC
13F
Company
0.15%
283,485
$10,636,000 30 Sep 2020
13F
Bank of New York Mellon Corp
13F
Company
0.13%
247,936
$9,303,000 30 Sep 2020
13F
AMERICAN CENTURY COMPANIES INC
13F
Company
0.12%
222,967
$8,366,000 30 Sep 2020
13F
HighTower Advisors, LLC
13F
Company
0.11%
220,308
$8,267,000 30 Sep 2020
13F
Ensign Peak Advisors, Inc
13F
Company
0.11%
206,651
$7,753,000 30 Sep 2020
13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
13F
Company
0.09%
174,395
$6,543,300 30 Sep 2020
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
0.09%
165,337
$6,203,000 30 Sep 2020
13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC
13F
Company
0.08%
153,875
$5,773,000 30 Sep 2020
13F
Fernwood Investment Management, LLC
13F
Company
0.07%
143,835
$5,397,000 30 Sep 2020
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.07%
132,175
$4,959,000 30 Sep 2020
13F
Man Group plc
13F
Company
0.06%
124,022
$4,653,000 30 Sep 2020
13F
STATE OF WISCONSIN INVESTMENT BOARD
13F
Company
0.06%
116,800
$4,382,000 30 Sep 2020
13F
CITADEL ADVISORS LLC
13F
Company
0.06%
113,618
$4,263,000 30 Sep 2020
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.06%
110,202
$4,135,000 30 Sep 2020
13F
WCM INVESTMENT MANAGEMENT, LLC
13F
Company
0.05%
105,796
$3,969,000 30 Sep 2020
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.05%
103,984
$3,901,000 30 Sep 2020
13F
SILVERCREST ASSET MANAGEMENT GROUP LLC
13F
Company
0.05%
93,542
$3,510,000 30 Sep 2020
13F
RHUMBLINE ADVISERS
13F
Company
0.05%
91,417
$3,430,000 30 Sep 2020
13F
GSA CAPITAL PARTNERS LLP
13F
Company
0.04%
79,890
$2,997,000 30 Sep 2020
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.04%
79,256
$2,974,000 30 Sep 2020
13F
Parkman Healthcare Partners LLC
13F
Company
0.04%
75,228
$2,823,000 30 Sep 2020
13F
Grace Capital
13F
Company
0.04%
73,425
$2,754,000 30 Sep 2020
13F
Atika Capital Management LLC
13F
Company
0.03%
62,500
$2,345,000 30 Sep 2020
13F

Institutional Holders of BridgeBio Pharma, Inc. - Common Stock (BBIO) as of Q4 2020

As of 31 Dec 2020, BridgeBio Pharma, Inc. - Common Stock (BBIO) was held by 160 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 121,079,579 shares. The largest 10 holders included Kohlberg Kravis Roberts & Co. L.P., VIKING GLOBAL INVESTORS LP, PERCEPTIVE ADVISORS LLC, BlackRock Inc., VANGUARD GROUP INC, HILLHOUSE CAPITAL ADVISORS, LTD., Aisling Capital Management LP, AMERICAN INTERNATIONAL GROUP, INC., SC US (TTGP), LTD., and STATE STREET CORP. This page lists 160 institutional shareholders reporting positions in this security for the Q4 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2020 vs Q3 2020 Across Filers

Q3 2020 holders
128
Q4 2020 holders
160
Holder diff
32
Investor Q3 2020 Shares Q4 2020 Shares Share Diff Share Chg % Q3 2020 Value $ Q4 2020 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .